For instance, the understanding of the role played by hepatocyte apoptosis and insulin resistance in the pathobiology of liver injury has enabled the development of promising biomarkers of NASH, such as caspase-cleaved cytokeratin 18 fragments or numerous different adipokines. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.